Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Baton Rouge, Louisiana 70808


Purpose:

We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone and a portion-controlled diet and metformin with a standard diet.


Study summary:

A total of 60 male and female type 2 diabetic subjects will be recruited and randomized into 1 of 3 treatment groups for the 4 months long trial 1. ACTOS plus a standard diet 2. ACTOS plus a portion-controlled diet 3. Metformin plus a standard diet. The end-point of the trial is the change in body fat content from baseline to the end of the trial


Criteria:

Inclusion Criteria: - Men and women age 35 to 75 who have type 2 diabetes mellitus Exclusion Criteria: - Individuals with co-existing other diseases


NCT ID:

NCT00219440


Primary Contact:

Principal Investigator
George A Bray, MD
Pennington Center


Backup Contact:

N/A


Location Contact:

Baton Rouge, Louisiana 70808
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.